Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TCC”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableStudy completedNCT02811952
What this trial is testing

Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients

Who this might be right for
Bladder Cancer
Carmel Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00101608
What this trial is testing

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Transitional Cell CarcinomaBladder NeoplasmsKidney Neoplasms+3 more
Bristol-Myers Squibb 150
Testing effectiveness (Phase 2)UnknownNCT04671407
What this trial is testing

The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer

Who this might be right for
TCC
Kaplan Medical Center 150
Not applicableEnded earlyNCT02586519
What this trial is testing

Pressure-Sensing Insoles in the Neuropathic Ulcer Treatment Pathway

Who this might be right for
DiabetesDiabetes ComplicationsNeuropathy+2 more
University of Calgary 42
Not applicableStudy completedNCT07321613
What this trial is testing

Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients

Who this might be right for
Hepatocellular Cancer (HCC)
Shanghai Zhongshan Hospital 545
Testing effectiveness (Phase 2)Active Not RecruitingNCT00756639
What this trial is testing

Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT01600339
What this trial is testing

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

Who this might be right for
Urothelial Carcinoma
Rambam Health Care Campus 19
Testing effectiveness (Phase 2)Ended earlyNCT02401542
What this trial is testing

Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Cell CarcinomaUrinary Bladder DiseaseUrological Diseases
Rainier Therapeutics 71
Not applicableUnknownNCT01551342
What this trial is testing

Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology

Who this might be right for
Bladder Cancer Transitional Cell Carcinoma
Zetiq Technologies 500
Testing effectiveness (Phase 2)Study completedNCT01610492
What this trial is testing

Belimumab in Idiopathic Membranous Glomerulonephropathy

Who this might be right for
Glomerulonephritis, Membranous
GlaxoSmithKline 14
Testing effectiveness (Phase 2)Ended earlyNCT00268450
What this trial is testing

Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery

Who this might be right for
Bladder Cancer
Medical University of South Carolina 21
Testing effectiveness (Phase 2)WithdrawnNCT01762852
What this trial is testing

Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00749619
What this trial is testing

Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?

Who this might be right for
End Stage Renal DiseaseHemodialysis
Western Galilee Hospital-Nahariya
Large-scale testing (Phase 3)Study completedNCT00028756
What this trial is testing

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

Who this might be right for
Stage III Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder
European Organisation for Research and Treatment of Cancer - EORTC 285
Early research (Phase 1)Ended earlyNCT05121948
What this trial is testing

HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)

Who this might be right for
Squamous Cell Carcinoma of Head and NeckColo-rectal CancerNon Small Cell Lung Cancer+3 more
HiberCell, Inc. 35
Not applicableEnded earlyNCT01563796
What this trial is testing

Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer

Who this might be right for
HematuriaDysuriaBladder Cancer
Medical Diagnostic Laboratories, LLC 1,115
Not applicableStudy completedNCT07259798
What this trial is testing

Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors.

Who this might be right for
Urinary Bladder Cancer
Ain Shams University 50
Early research (Phase 1)UnknownNCT04147182
What this trial is testing

Perioperative Intravesical Instilation of Hypertonic Saline Following Bladder Tumor Resection

Who this might be right for
TCC
Dan Leibovici 15
Early research (Phase 1)Study completedNCT03144999
What this trial is testing

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Who this might be right for
Dry Age-related Macular Degeneration
Janssen Research & Development, LLC 17
Testing effectiveness (Phase 2)WithdrawnNCT03935347
What this trial is testing

Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial Carcinoma+3 more
Roswell Park Cancer Institute
Load More Results